Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/06 → 3/31/13 |
Funding
- Tibotec Pharmaceuticals Ltd: $17,605.00
A Phase II randomized, double-blinded, placebo controlled trial to investigate the efficacy, tolerability and safety of TMC 125 as part of
- Greenberg, Richard (PI)